Stål, Olle
Linköping University · Region Östergötland
3 papers on CoChatORCID 0000-0002-8290-0592
Most cited papers
- Verified
Requirement for CDK4 kinase function in breast cancer
Yu, Q., Sicinska, E., Geng, Y., Ahnström, M., Zagozdzon, A., Kong, Y., Gardner, H., Kiyokawa, H., Harris, L. N., Stål, O., et al. (2006) · Cancer Cell
Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer
Cited by 429
- Verified
The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo
Djerf Severinsson, E. A., Trinks, C., Gréen, H., Abdiu, A., Hallbeck, A.-L., Stål, O., & Walz, T. M. (2011) · Biochemical and Biophysical Research Communications
HER2/EGFR in Cancer ResearchMelanoma and MAPK Pathways
Cited by 24
- Verified
17β-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer
Sivik, T., Gunnarsson, C., Fornander, T., Nordenskjöld, B., Skoog, L., Stål, O., & Jansson, A. (2012) · PLoS ONE
Breast Cancer Treatment StudiesEstrogen and related hormone effects
Cited by 17
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free